Mortality associated with the use of non-vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban.
Cancer Med
; 10(20): 7079-7088, 2021 10.
Article
in En
| MEDLINE
| ID: mdl-34464520
Key words
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Atrial Fibrillation
/
Antithrombins
/
Venous Thromboembolism
/
Rivaroxaban
/
Dabigatran
/
Neoplasms
Type of study:
Risk_factors_studies
Country/Region as subject:
Asia
Language:
En
Journal:
Cancer Med
Year:
2021
Type:
Article
Affiliation country:
Taiwan